why choose us

Clinical Trials Search

Showing 13,190 of 132,366 result(s)
Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Status: Completed

Condition: Hidradenitis Suppurativa

Interventions: Spesolimab Formulation 1

Date: 2023-04-06

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Status: NOT_YET_RECRUITING

Condition: Prostate Cancer Diagnosis

Interventions: Subjects will undergo DCFPyL PET;CT imaging and mpMRI imaging prior to the prostate biopsy.
The decision for biopsy targets will be made bas

Date: 2023-04-06

Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy

Status: Completed

Condition: Head and Neck Cancer

Interventions:

Injection of MSCs into submandibular glands at pre-specified dose level:

  • Dose -1: 5 (4 - 6) x10^6 MSCs (to be used only if Dose level 1

    Date: 2023-04-06

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Status: Completed

Condition: Parkinson's Disease

Interventions: BIA 28-6156 10 mg, once daily, oral administration.

Date: 2023-04-06

A Study of TAK-227 in Healthy Adults

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: TAK-227 capsules.

Date: 2023-04-06

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Status: Completed

Condition: Thrombotic Microangiopathies

Interventions: Treatment with narsoplimab 4 mg;kg will be administered

Date: 2023-04-06

Radicle Calm 2: A Study of Health and Wellness Products on Feelings of Anxiety, Stress, and Health Outcomes

Status: ACTIVE_NOT_RECRUITING

Condition: Anxiety

Interventions: Participants will use their Radicle Calm Active Study Product 1.1 as directed for a period of 6 weeks.

Date: 2023-04-06

TRAQinform Assessment of Immunotherapy Response

Status: Completed

Condition: Melanoma

Interventions:

This prospective, non-interventional clinical study will enroll patients with metastatic melanoma, who have been selected by their oncologist to re

Date: 2023-04-06

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Status: Completed

Condition: Pancreas Adenocarcinoma

Interventions:

The intervention will be administered on an outpatient basis.
The patients on this study will begin treatment with GA for one month and then t

Date: 2023-04-06